+1-408-387-5899

Media


Media

Acceliant Announces the Release of a White Paper Titled "EDC and ePRO - Modular, Disparate, and Single-System Approaches to Collecting Data"


06 Mar, 2013

Acceliant Logo
Herndon, Virginia, March 06, 2013 - Acceliant, a global technology provider of innovative solutions in eClinical trials, released a white paper titled "EDC and ePRO - Modular, Disparate, and Single-System Approaches to Collecting Data". The white paper emphasizes the advantages of an integrated single-system approach for data collection over the prevalent modular and disparate systems.

Operational efficiency is one of the key challenges faced by the clinical trial industry. CROs are briskly seeking solutions that considerably reduce the R&D costs and minimize the risks involved in clinical trials. Usage of an integrated single-system for data collection is gaining momentum due to its enhanced functionality.

The topics discussed in this "EDC and ePRO" white paper include:

  • Multiple Systems for Data Collection and Analysis - Challenges
  • Integration of Modular and Disparate Systems - Risks & Mitigation
  • Advantages of a Single-System Approach

Speaking on the release, Ven Thangaraj, CTO of Acceliant, said, "In a challenging global economy, cost effective collection of clinical trial data poses critical challenge to CROs. Acceliant has successfully leveraged the integration of EDC and ePRO enabling an efficient and cost effective analysis of clinical trial studies. The topics discussed in "EDC and ePRO" white paper illustrate Acceliant's adeptness as a clinical trial solution provider."

To download a copy of this white paper, please click here.

Acceliant eClinical Suite

Acceliant eClinical Suite is competitive in meeting the challenges of today’s dynamic market conditions. The Acceliant eClinical Suite is a pre-eminent offering that continues its 12-year history of providing innovative solutions for the life sciences industry. The Acceliant eClinical Suite is robust, scalable, and flexible. It has been proven by more than 350 Phase I-IV trials, covering all therapeutic areas and medical device trials. Engineered for agility, our service model differentiators enable us to implement and deploy in response to the data, functional, and analytic needs of clinical trials.

Prashant Bhavaraju
CMO
info@acceliant.com
+1-408-387-5899